BCL2L1 and breast carcinoma: Notably, the frequency of MCL1 amplification and mRNA expression exceeds both BCL-2 (~9%) and BCL-XL (~27%) across all major subtypes of breast cancer, suggestive of a specific importance of MCL-1 in breast tumourigenesis [39–43].